The CenterWatch 2006 European Investigative Site Survey marks the fifth time CenterWatch has surveyed investigative sites—those front-line researchers conducting clinical trials in Europe. MDS Pharma earned the top score for contract research organizations, improving from third place in the 2004 survey.
The factors rated most important by sites concerning CRO performance include being organized and prepared for a study, knowledge level of CRAs/monitors, quality of protocol design, timeliness of availability of the study drug, and simplicity of the case report form—critical aspects of study success.
-The complete article appears in CenterWatch Monthly's June 2006 issue.
-To read this article, or any other CenterWatch stories, please click here.